Aeterna Zentaris to Present at Upcoming Biotech Showcase Conference in San Francisco

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\nQUÉBEC CITY, Jan. 6, 2015 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the \"Company\") today announced that the Company's Chairman and CEO, David Dodd, will be presenting a corporate overview at the 7th annual Biotech Showcase Conference on Wednesday, January 14, 2015, at 3:30 pm (Pacific), in the C-Mission II room (4th floor) of the Parc 55 Wyndham San Francisco – Union Square Hotel. \n\nA live audio and slide webcast of the presentation will be available via the Company's website at www.aezsinc.com in the \"Newsroom\" section, under \"Events and Webcasts\". A replay of the webcast will also be available on the Company's website for a period of 90 days. \n\nAbout Aeterna Zentaris Inc.\n\nAeterna Zentaris is a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. For more information, visit www.aezsinc.com.\n\n \nSOURCE Aeterna Zentaris Inc.\n\n\n\nPaul Burroughs, Director of Communications, (418) 652-8525 ext. 406, [email protected] CNW Group 2015","length":1744,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.